Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'VINDESINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 279 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    2. Kruczynski, A; Hill, BT
      Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    3. Bretti, S; Manzin, E; Celano, A; Ritorto, G; Loddo, C; Berruti, A
      Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: A single institution phase II study

      ONCOLOGY REPORTS
    4. Robinet, G; Thomas, P; Breton, JL; Lena, H; Gouva, S; Dabouis, G; Bennouna, J; Souquet, PJ; Balmes, P; Thiberville, L; Fournel, P; Quoix, E; Riou, R; Rebattu, P; Perol, M; Paillotin, D; Mornex, F
      Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95-1

      ANNALS OF ONCOLOGY
    5. Breathnach, OS; Freidlin, B; Conley, B; Green, MR; Johnson, DH; Gandara, DR; O'Connell, M; Shepherd, FA; Johnson, BE
      Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results

      JOURNAL OF CLINICAL ONCOLOGY
    6. Monnet, I; Soulie, P; de Cremoux, H; Saltiel-Voisin, S; Bekradda, M; Saltiel, JC; Brain, E; Dupont-Andre, G; Cvitkovic, E
      Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    7. Tsuchiya, S; Ohe, Y; Sugiura, T; Fuwa, N; Kitamoto, Y; Mori, K; Kobayashi, H; Nakata, K; Sawa, T; Hirai, K; Etoh, T; Saka, H; Saito, A; Fukuda, H; Ishizuka, N; Saijo, N
      Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601)

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    8. Bradner, WT
      Mitomycin C: a clinical update

      CANCER TREATMENT REVIEWS
    9. Tjan-Heijnen, VCG; Groen, HJM; Schramel, FMNH; Stoter, G
      Consensus conference on palliative treatment of stage IV non-small cell lung cancer - Consensus Meeting of the Netherlands Society for Medical Oncology and the Taskforce on Lung Cancer of the Dutch Society of Physicians for Lung Diseases and Tuberculosis

      NETHERLANDS JOURNAL OF MEDICINE
    10. Nieboer, P; Mulder, NH; Van Der Graaf, WTA; Willemse, PHB; Hospers, GAP
      Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma

      ANTICANCER RESEARCH
    11. Montalar, J; Morales, S; Maestu, I; Camps, C; Vadell, C; Garcia, R; Yuste, AL; Torregrosa, D; Segura, A
      Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer

      LUNG CANCER
    12. Palmeri, S; Leonardi, V; Gebbia, V; De Bella, MT; Ferrau, F; Faillu, G; Spatafora, M; Valenza, R; Di Vita, G; Vitello, S; Carroccio, R; Sciortino, G; Vaglica, M; Accurso, V; Agostara, B; Licata, G
      Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial

      LUNG CANCER
    13. Horvath, L; Boyer, M; Clarke, S; Beale, P; Beith, J; Underhill, C; Stockler, M; Bishop, J
      Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer

      LUNG CANCER
    14. De Pas, T; de Braud, F; Mandala, M; Curigliano, G; Catania, C; Ferretti, G; Sozzi, P; Solli, P; Goldhirsch, A
      Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine

      LUNG CANCER
    15. Georgoulias, V; Papadakis, E; Alexopoulos, A; Tsiafaki, X; Rapti, A; Veslemes, M; Palamidas, P; Vlachonikolis, I
      Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

      LANCET
    16. Pisters, KMW
      Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    17. Belani, C
      Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non-small cell lung cancer: Interim analysis

      SEMINARS IN ONCOLOGY
    18. Nishio, K; Nakamura, T; Koh, Y; Kanzawa, F; Tamura, T; Saijo, N
      Oncoprotein 18 overexpression Increases the sensitivity to vindesine in the Human hung Carcinoma Cells

      CANCER
    19. Sculier, JP; Ghisdal, L; Berghmans, T; Branle, F; Lafitte, JJ; Vallot, F; Meert, AP; Lemaitre, F; Steels, E; Burniat, A; Mascaux, C; Paesmans, M
      The role of mitomycin in the treatment of non small cell lung cancer: a systematic review with meta-analysis of the literature

      BRITISH JOURNAL OF CANCER
    20. Jagetia, GC; Adiga, SK
      Correlation between cell survival and micronuclei formation in V79 cells treated with vindesine before exposure to different doses of gamma-radiation

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    21. Gridelli, C; Daniele, B
      Originality, benefits and difficulties of clinical research performed by cooperative groups: the experience of an Italian Lung Cancer Study Group

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    22. Retsas, S; Mohith, A; Bell, J; Horwood, N; Alexander, H
      Melanoma and additional primary cancers

      MELANOMA RESEARCH
    23. Monnerat, C; Le Chevalier, T
      Chemotherapy for non-small-cell lung carcinoma, a look at the past decade

      ANNALS OF ONCOLOGY
    24. Kubota, K; Tamura, T; Fukuoka, M; Furuse, K; Ikegami, H; Ariyoshi, Y; Kurita, Y; Saijo, N
      Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902

      ANNALS OF ONCOLOGY
    25. Iqbal, M; Marshall, E; Green, JA
      Ten-year survival in advanced malignant melanoma following treatment with interferon and vindesine

      ANNALS OF ONCOLOGY
    26. Miller, VA; Krug, LM; Ng, KK; Pizzo, B; Perez, W; Heelan, RT; Kris, MG
      Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    27. Lorusso, V; Carpagnano, F; Frasci, G; Panza, N; Di Rienzo, G; Cisternino, ML; Napoli, G; Orlando, S; Cinieri, S; Brunetti, C; Palazzo, S; De Lena, M
      Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    28. Sandler, AB; Nemunaitis, J; Denham, C; von Pawel, J; Cormier, Y; Gatzemeier, U; Mattson, K; Manegold, C; Palmer, MC; Gregor, A; Nguyen, B; Niyikiza, C; Einhorn, LH
      Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    29. Marinina, J; Shenderova, A; Mallery, SR; Schwendeman, SP
      Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres

      PHARMACEUTICAL RESEARCH
    30. Lee, KS; Shim, YM; Han, JH; Kim, JG; Ahn, YC; Park, KC; Jung, KJ
      Primary tumors and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: Serial CT findings with pathologic correlation

      JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
    31. Takigawa, N; Segawa, Y; Ueoka, H; Kiura, K; Tabata, M; Shibayama, T; Takata, I; Miyamoto, H; Eguchi, K; Harada, M
      Combination of nedaplatin and vindesine for treatment of relapsed or refractory non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    32. McLaren, BR; Robinson, BWS; Lake, RA
      New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    33. Fujita, A; Takabatake, H; Tagaki, S; Sekine, K
      Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    34. Ahn, AB; Ko, WK; Lee, JG; Shim, KY; Jeung, HC; Park, JO; Yoo, NC; Kim, BS; Kim, SK; Kim, SK; Kim, JH
      Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    35. Recchia, F; Sica, G; De Filippis, S; Rosselli, M; Saggio, G; Guerriero, G; Pompili, P; Rea, S
      Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study

      ANTICANCER RESEARCH
    36. Gridelli, C; Cigolari, S; Maiorino, A; Ianniello, GP; Brancaccio, L; Rossi, A; De Cataldis, G; Pedicini, T; Maiorino, L; Barletta, E; Di Lanno, M; Bilancia, D; Crispino, C; Barzelloni, ML; Masullo, P; D'Aniello, R; Manzione, L
      Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study

      LUNG CANCER
    37. Herrero, CC; Martinez, EN; Jaime, AB
      Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study

      LUNG CANCER
    38. Barone, C; Corsi, DC; Pozzo, C; Cassano, A; Alvaro, G; Colloca, G; Landriscina, M; Astone, A
      Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer

      ONCOLOGY
    39. Hokamura, N; Kato, H; Tachimori, Y; Watanabe, H; Yamaguchi, H; Nakanishi, Y
      Preoperative chemotherapy for esophageal carcinoma with intramural metastasis

      JOURNAL OF SURGICAL ONCOLOGY
    40. Johnson, DH
      Evolution of cisplatin-based chemotherapy in non-small cell lung cancer - A historical perspective and the eastern cooperative oncology group experience

      CHEST
    41. Feun, LG; Savaraj, M; Hurley, J; Marini, A; Lai, SH
      A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in thetreatment of patients with advanced malignant melanoma

      CANCER
    42. Robinet, G; Thomas, P; Perol, M; Vergnenegre, A; Lena, H; Taytard, A; Paillotin, D; Bessa, E; Schuller-Lebeau, MP
      Phase II study of docetaxel in inoperable advanced non small cell lung cancer

      BULLETIN DU CANCER
    43. Sculier, JP; Lafitte, JJ; Paesmans, M; Thiriaux, J; Alexopoulos, CG; Baumohl, J; Schmerber, J; Koumakis, G; Florin, MC; Zacharias, C; Berghmans, T; Mommen, P; Ninane, V; Klastersky, J
      Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer

      BRITISH JOURNAL OF CANCER
    44. Gridelli, C; Frontini, L; Perrone, F; Gallo, C; Gulisano, M; Cigolari, S; Castiglione, F; Robbiati, SF; Gasparini, G; Ianniello, GP; Farris, A; Locatelli, MC; Felletti, R; Piazza, E
      Gemcitabine plus vinorelbine in advanced non small cell lung cancer: a phase II study of three different doses

      BRITISH JOURNAL OF CANCER
    45. Lage, H; Helmbach, H; Dietel, M; Schadendorf, D
      Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance

      BRITISH JOURNAL OF CANCER
    46. Berthelot, JM; Will, BP; Evans, WK; Coyle, D; Earle, CC; Bordeleau, L
      Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    47. Haugen, BR
      Management of the patient with progressive radioiodine non-responsive disease

      SEMINARS IN SURGICAL ONCOLOGY
    48. Coukell, AJ; Noble, S; Faulds, D
      Vinorelbine in advanced non-small cell lung cancer - A pharmacoeconomic review

      PHARMACOECONOMICS
    49. Masutani, M; Tsujino, I; Fujie, T; Yamaguchi, M; Miyagi, K; Yano, T; Takahashi, N; Koya, Y; Horie, T
      Moderate dose-intensive chemotherapy for patients with non-small cell lungcancer: Randomized trial, can it improve survival of patients with good performance status?

      ONCOLOGY REPORTS
    50. Stathopoulos, GP; Rigatos, S; Malamos, NA
      Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin

      ONCOLOGY REPORTS
    51. Ritz-Quillac, L; Machet, L; Machet, MC; Vedere, V; Vaillant, L; Lorette, G
      Bone involvement in a case of Kaposi sarcoma

      DERMATOLOGY
    52. De Leyn, P; Vansteenkiste, J; Deneffe, G; Van Raemdonck, D; Coosemans, W; Lerut, T
      Result of induction chemotherapy followed by surgery in patients with stage IIIA N2NSCLC: importance of pre-treatment mediastinoscopy

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    53. Tajiri, T; Suita, S; Shono, K; Kubota, M; Taguchi, T; Yamanouchi, K; Noguchi, S; Tsuneyoshi, M
      Lung cancer in a child with a substantial family history of cancer

      EUROPEAN JOURNAL OF PEDIATRIC SURGERY
    54. Jassem, J
      Chemotherapy of advanced non-small cell lung cancer

      ANNALS OF ONCOLOGY
    55. Gralla, R; Harper, P; Johnson, S; Delgado, FM
      Vinorelbine (Navelbine (R)) in the treatment of non-small-cell lung cancer: Studies with single-agent therapy and in combination with cisplatin

      ANNALS OF ONCOLOGY
    56. Greco, FA; Hainsworth, JD
      Paclitaxel-based therapy in non-small-cell lung cancer: Improved third generation chemotherapy

      ANNALS OF ONCOLOGY
    57. Quoix, E
      Nature of chemotherapy in stage IV

      REVUE DES MALADIES RESPIRATOIRES
    58. Comella, P; Frasci, G; Panza, N; Manzione, L; Lorusso, V; Di Rienzo, G; Cioffi, R; De Cataldis, G; Maiorino, L; Bilancia, D; Nicolella, G; Natale, M; Carpagnano, F; Pacilio, C; De Lena, M; Bianco, A; Comella, G
      Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized study of the Southern ItalyCooperative Oncology Group

      JOURNAL OF CLINICAL ONCOLOGY
    59. Crino, L; Scagliotti, GV; Ricci, S; De Marinis, F; Rinaldi, M; Gridelli, C; Ceribelli, A; Bianco, R; Marangolo, M; Di Costanzo, F; Sassi, M; Barni, S; Ravaioli, A; Adamo, V; Portalone, L; Cruciani, G; Masotti, A; Ferrara, G; Gozzelino, F; Tonato, M
      Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project

      JOURNAL OF CLINICAL ONCOLOGY
    60. Furuse, K; Kawahara, M; Nishiwaki, Y; Fukuoka, M; Takada, M; Miyashita, M; Ohashi, Y
      Phase I/II study of vinorelbine, mitomycin, and cisplatin for stage IIIB or IV non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    61. Hosomi, Y; Ohe, Y; Mito, K; Uramoto, H; Moriyama, E; Tanaka, K; Kodama, K; Niho, S; Goto, K; Ohmatsu, H; Matsumoto, T; Hojo, F; Kakinuma, R; Nishiwaka, Y
      Phase I study of cisplatin and docetaxel plus mitomycin C in patients withmetastatic non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    62. Gidding, CEM; Meeuwsen-de Boer, GJ; Koopmans, P; Uges, DRA; Kamps, WA; de Graaf, SSN
      Vincristine pharmacokinetics after repetitive dosing in children

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    63. Subramanyan, S; Abeloff, MD; Bond, SE; Davidson, NE; Fetting, JH; Gordon, GB; Kennedy, MJ
      A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    64. Portalone, L; Lombardi, A; Antilli, A; Cruciani, AR; Magliacani, V; Mugnaini, L; Nunziati, F; Perrone, N; Signora, M; Salvati, F
      Treatment of inoperable non-small cell lung carcinoma stage IIIb and IV with cisplatin, epidoxorubicin, vindesine and lonidamine: A phase II study

      TUMORI
    65. Stenbygaard, LE; Sorensen, JB; Larsen, H; Dombernowsky, P
      Metastatic pattern in non-resectable non-small cell lung cancer

      ACTA ONCOLOGICA
    66. Huinink, WWT; Bergman, B; Chemaissani, A; Dornoff, W; Drings, P; Kellokumpu-Lehtinen, PL; Liippo, K; Mattson, K; von Pawel, J; Ricci, S; Sederholm, C; Stahel, RA; Wagenius, G; von Walree, N; Manegold, C
      Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer

      LUNG CANCER
    67. Stenbygaard, LE; Sorensen, JB
      Small bowel metastases in non-small cell lung cancer

      LUNG CANCER
    68. Quantin, X; Khial, F; Reme-Saumon, M; Michel, FB; Pujol, JL
      Concomitant brain radiotherapy and vinorelbine-ifosfamide-cisplatin chemotherapy in brain metastases of non-small cell lung cancer

      LUNG CANCER
    69. Thongprasert, S; Sanguanmitra, P; Juthapan, W; Clinch, J
      Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy

      LUNG CANCER
    70. Ginopoulos, P; Mastronikolis, NS; Giannios, J; Karana, A; Siabi, V; Karvelas, F; Rathossis, S; Apostolopoulos, N; Mastorakou, A
      A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC)

      LUNG CANCER
    71. Bengtson, EM; Rigas, JR
      A brief historical review of the development of chemotherapy for the treatment of advanced non-small cell lung cancer: Why we should look beyond platinum

      SEMINARS IN ONCOLOGY
    72. Wozniak, AJ
      Single-agent vinorelbine in the treatment of non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    73. Fossella, FV; Rigas, J
      The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens

      SEMINARS IN ONCOLOGY
    74. Sorensen, JB; Bergman, B; Nielsen, AL; Krarup, M; Dombernowsky, P; Hansen, HH
      Phase II study of Gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer

      BRITISH JOURNAL OF CANCER
    75. NATHAN FE; MASTRANGELO MJ
      SYSTEMIC THERAPY IN MELANOMA

      Seminars in surgical oncology
    76. JAGETIA GC; ADIGA SK
      INFLUENCE OF VINDESINE EXPOSURE ON THE MICRONUCLEUS FORMATION AND CELL-SURVIVAL IN V79 CELLS

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    77. JAGETIA GC; JYOTHI P; KRISHNAMURTHY H
      EFFECT OF VINDESINE SULFATE ON THE RADIATION-INDUCED ALTERATIONS IN MOUSE SPERMATOGENESIS - A FLOW CYTOMETRIC EVALUATION

      Mutation research. Fundamental and molecular mechanisms of mutagenesis
    78. WIERNIK PH; PHILLIPS V; CAMACHO FJ; OKEN MM; OCONNELL MJ
      METHYLGUAZONE, VINDESINE AND CISPLATIN FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MALIGNANT-LYMPHOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (PA482)

      Leukemia & lymphoma
    79. WAGNER W; STRIEHN E; KLINKE F; BOSSE U; RUBE C
      ANALYSIS OF LONG-TERM SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED NONSMALL CELL LUNG-CANCER

      Oncology Reports
    80. LOKICH J; ANDERSON N; BERN M; COCO F; GOTTHARDT S; OLIYNYK P; DOW E
      PACLITAXEL, CISPLATIN, ETOPOSIDE COMBINATION CHEMOTHERAPY - A MULTIFRACTIONATED BOLUS DOSE SCHEDULE FOR NONSMALL CELL LUNG-CANCER

      European journal of cancer
    81. Gridelli, C; Perrone, F; Monfardini, S
      Contra: Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?

      EUROPEAN JOURNAL OF CANCER
    82. HILLNER BE; SMITH TJ
      OVERVIEW OF ECONOMIC-ANALYSIS OF LE CHEVALIER VINORELBINE STUDY

      Oncology
    83. EVANS WK
      COST-EFFECTIVENESS OF VINORELBINE ALONE OR VINORELBINE PLUS CISPLATINFOR STAGE-IV NSCLC

      Oncology
    84. PAESMANS M
      PROGNOSTIC FACTORS

      Revue des maladies respiratoires
    85. WOZNIAK AJ; CROWLEY JJ; BALCERZAK SP; WEISS GR; SPIRIDONIDIS CH; BAKER LH; ALBAIN KS; KELLY K; TAYLOR SA; GANDARA DR; LIVINGSTON RB
      RANDOMIZED TRIAL COMPARING CISPLATIN WITH CISPLATIN PLUS VINORELBINE IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    86. BRADER KR; MORRIS M; LEVENBACK C; LEVY L; LUCAS KR; GERSHENSON DM
      CHEMOTHERAPY FOR CERVICAL-CARCINOMA - FACTORS DETERMINING RESPONSE AND IMPLICATIONS FOR CLINICAL-TRIAL DESIGN

      Journal of clinical oncology
    87. ZALCBERG J; MILLWARD M; BISHOP J; MCKEAGE M; ZIMET A; TONER G; FRIEDLANDER M; BARTER C; RISCHIN D; LORET C; JAMES R; BOUGON N; BERILLE J
      PHASE-II STUDY OF DOCETAXEL AND CISPLATIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    88. SCULIER JP; PAESMANS M; THIRIAUX J; LECOMTE J; BUREAU G; GINER V; EFREMIDIS A; LAFITTE JJ; BERCHIER MC; ALEXOPOULOS CG; ZACHARIAS C; MOMMEN P; NINANE V; KLASTERSKY J
      PHASE-III RANDOMIZED TRIAL COMPARING CISPLATIN AND CARBOPLATIN WITH OR WITHOUT IFOSFAMIDE IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    89. RECHNITZER S; BULZEBRUCK H; EBERT W; DRINGS P
      PRETREATMENT PROGNOSTIC FACTORS FOR SURVIVAL IN NON-SMALL-CELL LUNG-CANCER - A MULTIVARIATE-ANALYSIS OF 229 PATIENTS

      Onkologie
    90. KRUCZYNSKI A; COLPAERT F; TARAYRE JP; MOUILLARD P; FAHY J; HILL BT
      PRECLINICAL IN-VIVO ANTITUMOR-ACTIVITY OF VINFLUNINE, A NOVEL FLUORINATED VINCA ALKALOID

      Cancer chemotherapy and pharmacology
    91. NAKANISHI Y; KAWARADA Y; HIROSE N; NINOMIYA K; MIYAZAKI M; MIYAZAKI N; KURITA Y; KANEGAE H; OHGUSHI O; OGATA K; YAMAZAKI H; INUTSUKA S; HARA N
      PHASE-II TRIAL OF COMBINATION CHEMOTHERAPY WITH CISPLATIN, CARBOPLATIN AND ETOPOSIDE IN STAGE IIIB AND STAGE-IV SMALL-CELL LUNG-CANCER

      Cancer chemotherapy and pharmacology
    92. EMBREE L; GELMON K; TOLCHER A; HUDON N; HEGGIE J; DEDHAR C; LOGAN P; BALLY MB; MAYER LD
      PHARMACOKINETIC BEHAVIOR OF VINCRISTINE SULFATE FOLLOWING ADMINISTRATION OF VINCRISTINE SULFATE LIPOSOME INJECTION

      Cancer chemotherapy and pharmacology
    93. KLOCKER J; SABITZER H; RAUNIK W; WIESER S; SCHUMER J
      HYALURONIDASE AS ADDITIVE TO INDUCTION CHEMOTHERAPY IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

      Cancer letters
    94. REY F; ASTOUL P; MARQUESTE L; PETITE JM; BOUTIN C; VIALLAT JR
      CISPLATIN, IFOSFAMIDE, AND VINORELBINE COMBINATION CHEMOTHERAPY IN STAGE III-IV NON-SMALL-CELL LUNG-CANCER - A PHASE-II STUDY

      American journal of clinical oncology
    95. IACOBELLI S; IRTELLI L; SACCO R; MARTINO M; MASCITELLI E; BASILICO L; SCOGNAMIGLIO M; NATOLI C; FUSCO O; TINARI N; BELTRAMI V
      A PHASE-II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN AND VP-16 FOR STAGE-III UNRESECTABLE NONSMALL CELL LUNG-CANCER

      Anticancer research
    96. FISCHER JR; DRINGS P
      ROLE OF VINDESINE IN INDUCTION CHEMOTHERAPY IN LOCALLY-ADVANCED NON-SMALL-CELL LUNG-CANCER

      Journal of cancer research and clinical oncology
    97. ROTH JA; ATKINSON EN; FOSSELLA F; KOMAKI R; RYAN MB; PUTNAM JB; LEE JS; DHINGRA H; DECARO L; CHASEN M; HONG WK
      LONG-TERM FOLLOW-UP OF PATIENTS ENROLLED IN A RANDOMIZED TRIAL COMPARING PERIOPERATIVE CHEMOTHERAPY AND SURGERY WITH SURGERY ALONE IN RESECTABLE STAGE IIIA NON-SMALL-CELL LUNG-CANCER

      Lung cancer
    98. Martoni, A; Guaraldi, M; Piana, E; Strocchi, E; Petralia, A; Busutti, L; Preti, P; della Cuna, GR; Raimondi, M; Ferrara, G; Palomba, G; Lelli, G; Picece, V; Recaldin, E; Caffo, O; Ambrosini, G; Sarobba, G; Farris, A; Pannuti, F
      Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer

      LUNG CANCER
    99. GELDOF AA; MINNEBOO A; HEIMANS JJ
      VINCA-ALKALOID NEUROTOXICITY MEASURED USING AN IN-VITRO MODEL

      Journal of neuro-oncology
    100. GIACCONE G; MANEGOLD C; ROSELL R; GATZEMEIER U; QUOIX E
      AN UPDATE ON EUROPEAN RANDOMIZED STUDIES IN NONSMALL CELL LUNG-CANCER

      Seminars in oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 22:58:28